خلل فبرينوجين الدم (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "خلل فبرينوجين الدم" in Arabic language version.

refsWebsite

Global rank Arabic rank

17doi.org

2^nd place

5^th place

17nih.gov

4^th place

6^th place

4web.archive.org

1^st place

2archive.org

6^th place

3^rd place

2harvard.edu

18^th place

33^rd place

1worldcat.org

5^th place

4^th place

1wikidata.org

43^rd place

2^nd place

1medscape.com

719^th place

243^rd place

1unipa.it

low place

1archivesofpathology.org

low place

1whiterose.ac.uk

4,124^th place

7,292^nd place

1uptodate.com

3,771^st place

2,113^th place

archive.org

محمد هيثم الخياط (2009). المعجم الطبي الموحد: إنكليزي - فرنسي - عربي (بالعربية والإنجليزية والفرنسية) (ط. الرابعة). بيروت: مكتبة لبنان ناشرون، منظمة الصحة العالمية. ص. 743. ISBN:978-9953-86-482-2. OCLC:978161740. QID:Q113466993.
"Acquired dysfibrinogenemia secondary to mithramycin toxicity". The American Journal of the Medical Sciences. ج. 292 ع. 1: 53–5. 1986. DOI:10.1097/00000441-198607000-00011. PMID:2940861.

archivesofpathology.org

Hayes، T (2002). "Dysfibrinogenemia and thrombosis". Archives of Pathology & Laboratory Medicine. ج. 126 ع. 11: 1387–90. DOI:10.5858/2002-126-1387-DAT. PMID:12421146. مؤرشف من الأصل في 2022-05-10.

doi.org

"Clinical conditions responsible for hyperviscosity and skin ulcers complications" (PDF). Clinical Hemorheology and Microcirculation. ج. 67 ع. 1: 25–34. 2017. DOI:10.3233/CH-160218. PMID:28550239. مؤرشف من الأصل (PDF) في 2022-03-25.
"Acquired hypofibrinogenemia: current perspectives". Journal of Blood Medicine. ج. 7: 217–225. 2016. DOI:10.2147/JBM.S90693. PMID:27713652. {{استشهاد بدورية محكمة}}: الوسيط غير المعروف |PMCID= تم تجاهله يقترح استخدام |pmc= (مساعدة)صيانة الاستشهاد: دوي مجاني غير معلم (link)
"Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management". Journal of Thrombosis and Haemostasis. ج. 13 ع. 6: 909–19. 2015. DOI:10.1111/jth.12916. PMID:25816717.
"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis". Journal of the American Society of Nephrology. ج. 20 ع. 2: 444–51. 2009. DOI:10.1681/ASN.2008060614. PMID:19073821. {{استشهاد بدورية محكمة}}: الوسيط غير المعروف |PMCID= تم تجاهله يقترح استخدام |pmc= (مساعدة)
Hayes، T (2002). "Dysfibrinogenemia and thrombosis". Archives of Pathology & Laboratory Medicine. ج. 126 ع. 11: 1387–90. DOI:10.5858/2002-126-1387-DAT. PMID:12421146. مؤرشف من الأصل في 2022-05-10.
"Clinical Features and Management of Congenital Fibrinogen Deficiencies". Seminars in Thrombosis and Hemostasis. ج. 42 ع. 4: 366–74. 2016. DOI:10.1055/s-0036-1571339. PMID:27019462.
"Coagulation and fibrinolysis in gastric cancer". Annals of the New York Academy of Sciences. ج. 1404 ع. 1: 27–48. 2017. Bibcode:2017NYASA1404...27R. DOI:10.1111/nyas.13454. PMID:28833193.
"Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders". Seminars in Thrombosis and Hemostasis. ج. 42 ع. 4: 356–65. 2016. DOI:10.1055/s-0036-1571340. PMID:27019463.
"Fibrinogen splice variation and cross-linking: Effects on fibrin structure/function and role of fibrinogen γ' as thrombomobulin II" (PDF). Matrix Biology. 60–61: 8–15. 2017. DOI:10.1016/j.matbio.2016.09.010. PMID:27784620. مؤرشف من الأصل (PDF) في 2022-03-25.
"Fibrinogen and fibrin structure and functions". Journal of Thrombosis and Haemostasis. ج. 3 ع. 8: 1894–904. 2005. DOI:10.1111/j.1538-7836.2005.01365.x. PMID:16102057.
"Occurrence of thrombosis in rare bleeding disorders". Seminars in Thrombosis and Hemostasis. ج. 39 ع. 6: 684–92. 2013. DOI:10.1055/s-0033-1353391. PMID:23929306.
"Tranexamic acid--an old drug still going strong and making a revival". Thrombosis Research. ج. 135 ع. 2: 231–42. 2015. DOI:10.1016/j.thromres.2014.11.012. PMID:25559460.
"Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?". Nature. ج. 218 ع. 5137: 134–7. 1968. Bibcode:1968Natur.218..134B. DOI:10.1038/218134a0. PMID:5645286.
"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases". Clinical Journal of the American Society of Nephrology. ج. 8 ع. 9: 1515–23. 2013. DOI:10.2215/CJN.10491012. PMID:23704299. {{استشهاد بدورية محكمة}}: الوسيط غير المعروف |PMCID= تم تجاهله يقترح استخدام |pmc= (مساعدة)
"Acquired dysfibrinogenemia secondary to mithramycin toxicity". The American Journal of the Medical Sciences. ج. 292 ع. 1: 53–5. 1986. DOI:10.1097/00000441-198607000-00011. PMID:2940861.
"Acquired dysfibrinogenemia secondary to multiple myeloma". Acta Haematologica. ج. 120 ع. 2: 75–81. 2008. DOI:10.1159/000160182. PMID:18841003.
"A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange". Transfusion and Apheresis Science. ج. 48 ع. 1: 35–8. 2013. DOI:10.1016/j.transci.2012.06.021. PMID:22842111.

harvard.edu

ui.adsabs.harvard.edu

"Coagulation and fibrinolysis in gastric cancer". Annals of the New York Academy of Sciences. ج. 1404 ع. 1: 27–48. 2017. Bibcode:2017NYASA1404...27R. DOI:10.1111/nyas.13454. PMID:28833193.
"Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?". Nature. ج. 218 ع. 5137: 134–7. 1968. Bibcode:1968Natur.218..134B. DOI:10.1038/218134a0. PMID:5645286.

medscape.com

emedicine.medscape.com

Dysfibrinogenemia في موقع إي ميديسين

nih.gov

pubmed.ncbi.nlm.nih.gov

"Clinical conditions responsible for hyperviscosity and skin ulcers complications" (PDF). Clinical Hemorheology and Microcirculation. ج. 67 ع. 1: 25–34. 2017. DOI:10.3233/CH-160218. PMID:28550239. مؤرشف من الأصل (PDF) في 2022-03-25.
"Acquired hypofibrinogenemia: current perspectives". Journal of Blood Medicine. ج. 7: 217–225. 2016. DOI:10.2147/JBM.S90693. PMID:27713652. {{استشهاد بدورية محكمة}}: الوسيط غير المعروف |PMCID= تم تجاهله يقترح استخدام |pmc= (مساعدة)صيانة الاستشهاد: دوي مجاني غير معلم (link)
"Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management". Journal of Thrombosis and Haemostasis. ج. 13 ع. 6: 909–19. 2015. DOI:10.1111/jth.12916. PMID:25816717.
"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis". Journal of the American Society of Nephrology. ج. 20 ع. 2: 444–51. 2009. DOI:10.1681/ASN.2008060614. PMID:19073821. {{استشهاد بدورية محكمة}}: الوسيط غير المعروف |PMCID= تم تجاهله يقترح استخدام |pmc= (مساعدة)
Hayes، T (2002). "Dysfibrinogenemia and thrombosis". Archives of Pathology & Laboratory Medicine. ج. 126 ع. 11: 1387–90. DOI:10.5858/2002-126-1387-DAT. PMID:12421146. مؤرشف من الأصل في 2022-05-10.
"Clinical Features and Management of Congenital Fibrinogen Deficiencies". Seminars in Thrombosis and Hemostasis. ج. 42 ع. 4: 366–74. 2016. DOI:10.1055/s-0036-1571339. PMID:27019462.
"Coagulation and fibrinolysis in gastric cancer". Annals of the New York Academy of Sciences. ج. 1404 ع. 1: 27–48. 2017. Bibcode:2017NYASA1404...27R. DOI:10.1111/nyas.13454. PMID:28833193.
"Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders". Seminars in Thrombosis and Hemostasis. ج. 42 ع. 4: 356–65. 2016. DOI:10.1055/s-0036-1571340. PMID:27019463.
"Fibrinogen splice variation and cross-linking: Effects on fibrin structure/function and role of fibrinogen γ' as thrombomobulin II" (PDF). Matrix Biology. 60–61: 8–15. 2017. DOI:10.1016/j.matbio.2016.09.010. PMID:27784620. مؤرشف من الأصل (PDF) في 2022-03-25.
"Fibrinogen and fibrin structure and functions". Journal of Thrombosis and Haemostasis. ج. 3 ع. 8: 1894–904. 2005. DOI:10.1111/j.1538-7836.2005.01365.x. PMID:16102057.
"Occurrence of thrombosis in rare bleeding disorders". Seminars in Thrombosis and Hemostasis. ج. 39 ع. 6: 684–92. 2013. DOI:10.1055/s-0033-1353391. PMID:23929306.
"Tranexamic acid--an old drug still going strong and making a revival". Thrombosis Research. ج. 135 ع. 2: 231–42. 2015. DOI:10.1016/j.thromres.2014.11.012. PMID:25559460.
"Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?". Nature. ج. 218 ع. 5137: 134–7. 1968. Bibcode:1968Natur.218..134B. DOI:10.1038/218134a0. PMID:5645286.
"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases". Clinical Journal of the American Society of Nephrology. ج. 8 ع. 9: 1515–23. 2013. DOI:10.2215/CJN.10491012. PMID:23704299. {{استشهاد بدورية محكمة}}: الوسيط غير المعروف |PMCID= تم تجاهله يقترح استخدام |pmc= (مساعدة)
"Acquired dysfibrinogenemia secondary to mithramycin toxicity". The American Journal of the Medical Sciences. ج. 292 ع. 1: 53–5. 1986. DOI:10.1097/00000441-198607000-00011. PMID:2940861.
"Acquired dysfibrinogenemia secondary to multiple myeloma". Acta Haematologica. ج. 120 ع. 2: 75–81. 2008. DOI:10.1159/000160182. PMID:18841003.
"A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange". Transfusion and Apheresis Science. ج. 48 ع. 1: 35–8. 2013. DOI:10.1016/j.transci.2012.06.021. PMID:22842111.